The two day program will address key concerns such as cancer Immunotherapy, molecular targeted therapy, metabolomics in cancer tumour assessments & profiling, nanotechnology in cancer therapy, hormone therapy, stem cell Transplantation, surgical oncology, epigenetics, cancer genomics, cancer biomarkers, bio banking, non-invasive cancer diagnostics, organ specific cancers, cancer epidemiology and clinical trial in cancer research.

The Cancer Therapy and Diagnosis Congress will provide an international platform to meet and network with experts from around the globe through scientific and industry oriented sessions, panel discussions, symposiums, workshops and vibrant exhibition area.